BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 16951395)

  • 21. Distal biliary malignancy.
    Veillette G; Castillo CF
    Surg Clin North Am; 2008 Dec; 88(6):1429-47, xi. PubMed ID: 18992603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cholangiocarcinoma--bile ducts cancer].
    Dubaniewicz A; Dubaniewicz A
    Wiad Lek; 2003; 56(1-2):57-60. PubMed ID: 12901270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography.
    Cho ES; Park MS; Yu JS; Kim MJ; Kim KW
    J Comput Assist Tomogr; 2007; 31(1):72-8. PubMed ID: 17259836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unresectable hilar cholangiocarcinoma completely reduced by external radiation therapy.
    Kaido T; Imamura M
    Hepatogastroenterology; 2005; 52(63):725-7. PubMed ID: 15966192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surgical treatments for hilar cholangiocarcinoma].
    Liu YB; Jian ZX; Liu ZX; Ou JR
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1401-3. PubMed ID: 15604069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection and treatment of cholangiocarcinoma.
    Gores GJ
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S30-4. PubMed ID: 11084082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hilar inflammatory pseudotumor mimicking hilar cholangiocarcinoma.
    Deng FT; Li YX; Ye L; Tong L; Yang XP; Chai XQ
    Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):219-21. PubMed ID: 20382598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
    Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A; Maréchal R; Devière J; Van Laethem JL
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of cholangiocarcinomas: a comprehensive review.
    Yalcin S
    Hepatogastroenterology; 2004; 51(55):43-50. PubMed ID: 15011829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient with advanced intrahepatic cholangiocarcinoma with long-term survival successfully treated with a combination of surgery and chemotherapy.
    Morise Z; Sugioka A; Hoshimoto S; Kato T; Tanahashi Y; Ikeda M; Kagawa T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):545-8. PubMed ID: 18836811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.
    Lin G; Toh CH; Wu RC; Ko SF; Ng SH; Chou WC; Tseng JH
    Int J Clin Pract; 2008 Aug; 62(8):1199-205. PubMed ID: 17537192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Main bile duct carcinoma management. Our experience on 38 cases.
    Cavallaro A; Cavallaro V; Di Vita M; Cappellani A
    Ann Ital Chir; 2009; 80(2):107-11. PubMed ID: 19681291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A modern approach to malignant hilar biliary obstruction.
    Freeman ML; Sielaff TD
    Rev Gastroenterol Disord; 2003; 3(4):187-201. PubMed ID: 14668691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging of intrahepatic cholangiocarcinoma: 2. Hilar cholangiocarcinoma.
    Soyer P; Bluemke DA; Reichle R; Calhoun PS; Bliss DF; Scherrer A; Fishman EK
    AJR Am J Roentgenol; 1995 Dec; 165(6):1433-6. PubMed ID: 7484580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
    Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right trisectionectomy of the liver for intrahepatic cholangiocarcinoma with bile duct invasion in a Jehovah's Witness.
    Nishida S; Madariaga JR; Santiago S; Quintini C; Palaios E; Gyamfi A; Rico R; Hamamura K; Haider H; Moon JI; Levi DM; Casillas VJ; Bejarano PA; Tzakis AG
    J Hepatobiliary Pancreat Surg; 2007; 14(3):312-7. PubMed ID: 17520209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.